Clinical trials for Adrenocortical carcinoma
17 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT06487481Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical CarcinomaNational Cancer Institute (NCI) · PI: Naris Nilubol, M.D.
- RECRUITINGPhase 1NCT07189403A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerDaiichi Sankyo
- RECRUITINGPhase 2NCT06587802Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical CarcinomaSun Yat-sen University · PI: Shengjie Guo, doctor
- RECRUITINGNCT06279442Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian CohortLatin American Cooperative Oncology Group · PI: Milena Shizue Tariki
- RECRUITINGPhase 2NCT06333314Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIUNICANCER · PI: Thierry ANDRE, MD
- RECRUITINGPhase 2NCT06066333Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaMemorial Sloan Kettering Cancer Center · PI: Nitya Raj, MD
- RECRUITINGPhase 2NCT05563467Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.Maria Sklodowska-Curie National Research Institute of Oncology
- RECRUITINGPhase 2NCT05913427Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · PI: Alfredo Berruti
- RECRUITINGNCT05237934Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)National Cancer Institute (NCI) · PI: Jaydira Del Rivero, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT05036434Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical CarcinomaNational Cancer Center, Korea · PI: Tak Yun
- RECRUITINGPhase 2NCT04318730Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical CarcinomaWest China Hospital
- ACTIVE NOT RECRUITINGNCT04358107Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)National Cancer Institute (NCI) · PI: Jaydira Del Rivero, M.D.
- RECRUITINGPhase 2NCT03127774Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical CarcinomaColumbia University · PI: Kazuki Sugahara, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT02673333Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical CarcinomaMemorial Sloan Kettering Cancer Center · PI: Nitya Raj, MD
- ACTIVE NOT RECRUITINGNCT00568139Evaluation of Side Effects of MitotaneUniversity of Wuerzburg · PI: Martin Fassnacht, MD
- ACTIVE NOT RECRUITINGNCT00457587Preclinical Study Towards an Immunotherapy in Adrenocortical CarcinomaUniversity of Wuerzburg · PI: Martin Fassnacht, MD
- RECRUITINGNCT00453674German Adrenocortical Carcinoma RegistryUniversity of Wuerzburg · PI: Martin Fassnacht, MD